The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation

Connecticut Medicine

Volumn 69, Issue 2, 2005, Pages 91-94

  Sander, Stephen ^a,b   White, C Michael ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO; SOTALOL;

ADRENERGIC RECEPTOR BLOCKING; CARDIOTOXICITY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COST CONTROL; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ECONOMIC EVALUATION; EMERGENCY SURGERY; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; HYPOTENSION; LUNG FIBROSIS; LUNG TOXICITY; META ANALYSIS; NAUSEA; NIGHTMARE; PROPHYLAXIS; QT INTERVAL; REVIEW; RISK FACTOR; SIDE EFFECT; SINUS BRADYCARDIA; SYSTEMATIC REVIEW; THORAX SURGERY; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; SAFETY; THORACIC SURGICAL PROCEDURES;

EID: 13444272944     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. American Heart Association: Heart Disease and Stroke Statistics -2004 Update. Dallas, Texas: American Heart Association, 2003.
2. Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135:1061-73.
3. Rao V, Christakis GT, Weisel RD: Risk factors for stroke following coronary bypass surgery. J Card Surg 1995; 10:468-74.
4. Alexander KP, Anstrom KJ, Muhlbaier LH, et al: Outcomes of cardiac surgery in patients over 80 years: Results from the National Cardiac Network. J Am Coll Cardiol 2000; 35:731-8.
5. Crystal E, Connolly SJ, Sliek K, et al: Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002; 106:75-80.
6. Kowey PR, Taylor JE, Rials SJ, Marinchak K: Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69:963-5.
7. Laurer MS, Eagle KA, Buckly MJ, et al: Atrial Fibrillation following coronary artery bypass surgery. Prog Cardiol Dis 1989; 31: 367-78.
8. Crosby LH, Pifalo WB, Woll KR, Burkholder JA: Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990; 66:1520-2.
9. Giri S, White CM, Dunn AB, et al: Efficacy and safety of oral amiodarone for the prevention of atrial fibrillation after open heart surgery in the elderly: The Atrial Fibrillation Suppression Trial (AFIST). Lancet 2001; 357:830-6.
10. White CM, Giri S, Tsikouris J, et al: A comparison of two individual amiodarone regimens to placebo in open-heart surgery patients. Ann Thorac Surg 2002; 74:69-74.
11. White CM, Caron MF, Kalus JS, et al: Intravenous and oral amiodarone, atrial septal pacing, or both strategies to prevent postcardiothoracic surgery atrial fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003; 108[suppl II]:II-200-6.
12. Fermini B, Fossa A: The impact of drug-induced QT interval prolongation on drug discovery and development. Nature Reviews: Drug Discovery 2003; 2:439-47.
13. Dusman RE, Stanton MS, Miles WM, et al: Clinical features of amiodarone-induced toxicity. Circulation 19990; 82:51-9.
14. Hohnloser SH, Meinertz T, Dammbacher T, et al: Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study. Am Heart J 1991; 121:89-95.
15. Butler J, Harriss DR, Sinclair M, Westaby S: Amiodaroneprophylaxis for tachycardias after coronay artery sugery: A randomised, double-blind, placebo controlled trial. Br Heart J 1993; 70:56-60.
16. Daoud EG, Strickberger SA, Man KC, et al: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. NEng J Med 1997; 337(25):1785-91.
17. Guarnieri T, Nolan S, Gottlieb SO, et al: Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiology 1999; 34(2):343-7.
18. Redle JD, Khurana S, Marzan R, et al: Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999; 138:144-50.
19. Lee SH, Chang CM, Lu MJ, et al: Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2000; 70:157-61.
20. Treggiari-Venzi MM, Waeber JL, Perneger TV, et al: Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000; 85:690-5.
21. Dorge H, Schoendube FA, Schoberer M, et al: Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg 2000; 69:1358-62.
22. Maras D, Boskovic SD, Popovic Z, et al: Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J 2001; 141:e8.
23. Yazigi A, Rahbani P, Zeid HA, et al: Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothor Vasc Anesth 2002; 16(5):603-6.
24. Yagdi T, Nalbantgil S, Ayik F, Apaydin A, et al: Amiodarone reduces the incidence of atrial fibrillation after coronary bypass grafting. J Thoracic Cardiovasc Surg 2003; 125(6):1420-5.
25. Mitchell LB, Exner DV, Wyse DG, et al: Prophylactic amiodarone for the prevention of arrhythmias that begin early after revascularization, valvular repair, or replacement (PAPABEAR): Preliminary Results. Circulation 2004; 108(21):2723 [Abstract]
26. Kerstein J, Soodan A, Qamar, Q, et al: Giving IV and oral amdiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: The GAP Study. Chest 2004; 126:716-24.
27. Auer J, Weber T, Berent R, et al: A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: The pilot study of Prevention of Postoperative Atrial Fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004; 147:636-43.